Pandemic Pulse

Study on Sputnik Light (first component of Sputnik V) vaccine’s efficacy among the elderly in Argentina published in EClinicalMedicine journal

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces publication of a study in EClinicalMedicine (an open access peer-reviewed clinical journal published by The Lancet, one of the world’s most respected medical journals) on efficacy of Russian Sputnik Light coronavirus vaccine (the first component of Sputnik V vaccine) among the elderly in the […]

Pandemic Pulse

The single-component Sputnik Light vaccine authorized in Philippines

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved under the emergency use authorization procedure by the Food and Drug Administration (FDA) of the Republic of the Philippines. Sputnik Light vaccine based on human adenovirus serotype 26 is the first component […]

Pandemic Pulse

The world’s first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine (Sputnik Light) in Azerbaijan shows no serious adverse events or COVID infection cases following the vaccination

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces initial safety results of the world’s first study of a combination between the AstraZeneca vaccine (developed jointly with the University of Oxford) and the first component of the Sputnik V vaccine (Sputnik Light vaccine based on human adenovirus serotype 26) in the Republic of […]